… This article reports 3-year clinical and echocardiographic outcomes of inoperable patients
with severe symptomatic aortic stenosis from the only randomized trial of transcatheter aortic …

… aortic valve replacement (TAVR) has emerged as an effective therapy for high-risk and
inoperable patients … after TAVR and SAVR in high-risk patients with symptomatic severe AS;13 …

… Survival of Patients With Unoperated AS Kaplan-Meier survival for patients with unoperated
severe aortic stenosis (AS). Survival estimates ± 1 standard error; log-rank difference in …

… In our study, 64% of the inoperable patients were over 85 years … who do not undergo aortic
valve replacement: the potential … aortic-valve implantation for aortic stenosis in patients who …

Background— Transcatheter aortic valve replacement (TAVR) has been shown to improve
survival compared with standard therapy in patients with severe aortic stenosis who cannot …

… therapy in patients with severe aortic stenosis who were not … patients with aortic stenosis
who do not have reasonable surgical alternatives. The ultimate value of TAVR in such patients …

Background— Some patients with severe symptomatic aortic stenosis (AS) do not undergo
aortic valve replacement (AVR) despite demonstrated symptomatic and survival advantages …

Background— In patients with severe aortic stenosis who cannot have surgery, transcatheter
aortic valve replacement (TAVR) has been shown to improve survival and quality of life …

… an increased number of patients with degenerative calcific aortic stenosis. Surgical aortic
valve replacement is the treatment of choice for a vast majority of patients, offering symptomatic …

… We enrolled patients with severe symptomatic inoperable aortic stenosis and randomly … ,
which often included balloon aortic valvuloplasty. Patients and their treating physicians were not …